MTA2 and tauopathy: These changes were observed in all samples in all tauopathies with tau deposits, although with disease-dependent variability; lesions were more common following inoculation of AD, PART, and ARTAG followed by GGT than following inoculation of homogenates from PSP, PiD, and fFTLD-P301L (Figure 8; Table 1).